Alembic Limited (IN:ALEMBICLTD)
:ALEMBICLTD
Want to see IN:ALEMBICLTD full AI Analyst Report?
ALEMBICLTD Stock Chart & Stats
₹103.40
-₹1.48(-1.12%)
At close: 4:00 PM EST
₹103.40
-₹1.48(-1.12%)
Day’s Range― - ―
52-Week Range₹70.64 - ₹125.70
Previous CloseN/A
Volume165.88K
Average Volume (3M)22.23K
Market Cap
₹23.45B
Enterprise Value₹24.05B
Total Cash (Recent Filing)₹888.10M
Total Debt (Recent Filing)₹125.80M
Price to Earnings (P/E)10.8
Beta1.50
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.36%
Share Statistics
EPS (TTM)12.62
Shares Outstanding256,781,830
10 Day Avg. Volume15,327
30 Day Avg. Volume22,227
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)1.10
Price to Sales (P/S)11.55
P/FCF Ratio71.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA 50.8% year-over-year revenue increase demonstrates durable demand and successful expansion across branded formulations, generics and APIs. Sustained top-line growth supports ongoing R&D, regulatory filings for exports and scaling manufacturing capacity over the medium term.
Balance Sheet StrengthExtremely low leverage and a 93.4% equity ratio provide strong financial flexibility to fund capex, manufacturing scale-ups and R&D without heavy interest costs. This conservative capital structure lowers bankruptcy risk and supports multi-year strategic investments.
High Operational MarginsRobust gross and operating margins indicate efficient manufacturing, cost control and pricing power in APIs and finished dosages. Sustained margin levels enable reinvestment in product development and provide a buffer against pricing pressure in generic markets over the next several quarters.
Bears Say
Unusual Net MarginA reported 140% net margin is anomalous and likely reflects non-recurring items, reducing the reliability of headline profitability. If recurring profits are materially lower, forecasting, capital allocation and investor assessment of sustainable earnings will be impaired over the medium term.
Weak Cash ConversionLow free cash flow and operating cash conversion versus reported net income signal difficulty turning accounting profits into spendable cash. This constrains self-funding for capex, dividends or M&A and raises reliance on working capital or external financing for strategic initiatives.
Profit Metrics Inflation RiskAnalyst notes that profit measures may be inflated by one-off gains. Overstated profitability would distort ROE and margin trends, and could trigger downward revisions to expected recurring earnings, affecting medium-term planning and investor confidence.
Alembic Limited News
ALEMBICLTD FAQ
What was Alembic Limited’s price range in the past 12 months?
Alembic Limited lowest stock price was ₹70.64 and its highest was ₹125.70 in the past 12 months.
What is Alembic Limited’s market cap?
Alembic Limited’s market cap is ₹23.45B.
When is Alembic Limited’s upcoming earnings report date?
Alembic Limited’s upcoming earnings report date is May 07, 2026 which is in 3 days.
How were Alembic Limited’s earnings last quarter?
Alembic Limited released its earnings results on Feb 12, 2026. The company reported ₹2.342 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.342.
Is Alembic Limited overvalued?
According to Wall Street analysts Alembic Limited’s price is currently Overvalued.
Does Alembic Limited pay dividends?
Alembic Limited pays a Annually dividend of ₹2.4 which represents an annual dividend yield of 2.36%. See more information on Alembic Limited dividends here
What is Alembic Limited’s EPS estimate?
Alembic Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alembic Limited have?
Alembic Limited has 256,781,830 shares outstanding.
What happened to Alembic Limited’s price movement after its last earnings report?
Alembic Limited reported an EPS of ₹2.342 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.726%.
Which hedge fund is a major shareholder of Alembic Limited?
Currently, no hedge funds are holding shares in IN:ALEMBICLTD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Alembic Limited
Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is also involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. In addition, it operates co-generation plants with a total capacity of 11 MW; and wind power plants with a total capacity of 5 MW. The company also exports its products. Alembic Limited was founded in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Limited.
Technical Analysis
Alkem Laboratories Ltd.
―
Alembic Pharmaceuticals Limited
―
Aurobindo Pharma Ltd
―
Glenmark Pharmaceuticals Limited
―
IPCA Laboratories Limited
―